Menu
  • Join
  • Login
  • Contact
 

Search abstracts


COMPARATIVE SAFETY OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION

  • At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
  • Type: Poster
  • By: KAO, Chi-Lan (cathay general hospital, pharmacy, China Taiwan)
  • Co-author(s): Chi-Lan Kao: pharmacy, cathay general hospital, taipei, China Taiwan;Pharmacists, Association, taipei, China Taiwan
    Tsai-Ling Chiang: pharmacy, cathay general hospital, taipei, China Taiwan;Pharmacists, Association, taipei, China Taiwan
    Ting-Ching Wu: pharmacy, cathay general hospital, taipei, China Taiwan;Pharmacists, Association, taipei, China Taiwan
    Wan-Tsui Huang: pharmacy, cathay general hospital, taipei, China Taiwan;Pharmacists, Association, taipei, China Taiwan;School of Pharmacy, Taipei Medical University, taipei, China Taiwan
  • Abstract:

    Background

    Safety of different direct oral anticoagulants (DOACs) (dabigatran, rivaroxaban, edoxaban and apixaban) in patients with non-valvular atrial fibrillation (NVAF) has not been evaluated in clinical practice.

    .

    Methods

    This was a retrospective cohort study. We included patients with NVAF who initiated any of DOACs in the Cathay General

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 21 September 2019

FIP Congresses